News About: Pharm. Industry
Rift widens in KPMA
The leadership of the Korea Pharmaceutical Manufacturers Association (KPMA) is facing a backlash from within over the rumors that the second pharmaceutical body is to be established under the full support from the Min...
Type 2 diabetes market heats up
Despite the variety of efficacious oral anti-diabetics available to treat type 2 diabetes—many of them available generically—the unmet need in this disease remains high.
Merck’s Januvia (sitagliptin), which was fir...
Major pharmaceutical firms fare ill in 1Q
Korea's major drug firms performed worse in the first quarter of 2012 than three months earlier largely due to quick handling of their drug inventories to soften the impact from the government-mandated cuts in drug pr...
Sales of 10 largest multinational firms grow 3% in 2011
The combined sales of top 10 multinational drug firms in Korea grew a mere three percent on-year in 2011, while their net profit jumped 56.4 percent on average, data showed Monday.
The data compiled by Yakup.com, a...
Boryung’s research center to go global
Boryung’s research center marked the 30th anniversary Saturday in Ansan, pledging to expand its businesses abroad while creating opportunities to developed new drugs through cooperation with foreign firms.
“We will...
Drug makers seek to boost OTC sales
To soften the impact from government-mandated cuts in drug prices, major Korean drug makers are finding other ways to gear up the sales of over-the-counter (OTC) drugs to stem predicted losses.
In the process, howe...
KMPA in severe feud
The leadership of the Korea Pharmaceutical Manufacturers Association (KPMA) is facing a backlash as Korea’s leading pharmaceutical firms, the association’s former executive members, are still refusing to join in the n...
Some drug makers urged to handle expiring goods
The Korea Pharmaceutical Wholesaler Association announced Tuesday a list of several pharmaceutical firms who have been uncooperative in dealing with the return of expiring drugs.
BMS Korea, BRN Science and Galderma...
Pharmacists lash out at 11 drugmakers’ uncooperative attitude over
Pharmacists denounced Monday 11 foreign and domestic drug firms for their failure to submit a confirmatory note of compensation over the government’s mandatory drug price cuts from April 1.
The Korean Pharmaceutica...
Low margin squeezes drug wholesalers
So far, domestic wholesalers have had to cope with a low margin hovering at 6 to 7 percent given by multinational firms, but concerns are growing over the similar demand of local drug firms on their margin.
If this...
